About
We focus on developing RNA-based therapies and personalized human models, such as a retina-on-chip system, for rare neuro(sensory)metabolic diseases, with an emphasis on brain and retina-related conditions to evaluate these therapeutic strategies.
Research programs
Programs that are connected to this research group.